The world is changing, the environment is changing, and we all realize that the only constant thing is change. Like a living creature, a company must possess the capability of adapting to an environment that continues to change from time to time. Not many Indonesian companies have been able to endure, let alone continue to develop over a period of tens of years. One example of such an Indonesian company is PT Kalbe Farma Tbk. (Kalbe).
Today, Kalbe is recognized as the largest regional pharmaceutical company in Southeast Asia. However, perhaps few people realize it all started in a small garage in the Tanjung Priok area of North Jakarta, Indonesia. When they set up Kalbe on September 10, 1966, the six founders may not have imagined that Kalbe could ever become the success that it is today. The sharp vision, high sense of entrepreneurship and spirit of hard work displayed by the founders and all the employees have enabled Kalbe to continue to grow and become the large and successful company of today.
Living by its philosophy, Kalbe always moves on and continues to grow. It is not surprising that nowadays Kalbe sells its products to Asian and African markets, as an expansion of its Indonesian market. By the end of 2005, Kalbe was represented at seven markets, namely Malaysia, the Philippines, Thailand, Vietnam, Myanmar, Sri Lanka and South Africa.
Nowadays Kalbe is engaged in both the consumer health business and the pharmaceutical products business to fulfill the diverse needs of their customers through the creation of many strong brands. In developing its business network and markets, Kalbe continues to produce many innovative products. Kalbe certainly always tries its best to fulfill the health requirements of all their valued customers, both in Indonesia and overseas.
To play the role of an innovator, Kalbe commits itself to the area of research and development. The research and development activities cover the creation of new medicines and formulations, new systems and processes, and new knowledge, either through its own capabilities or through strategic alliances with international partners. Indeed, to grow Kalbe must continue to innovate and always be on the constant lookout for potential global opportunities.
To ensure the availability of information at any time, anywhere, Kalbe has started the improvement of information technology in the extended Kalbe Group. This information technology will be an enabler and accelerator for Kalbe in expanding the business and providing the best services to all its customers.
With its wide scale of business and range of innovative products that continue to be trendsetters in the marketplace, Kalbe is a business group that is always in the forefront. Nonetheless, Kalbe will never stop. In the future, Kalbe is determined to be known not only as a regional company, but also as a global company active in the healthcare business and serving all the health needs of the general public.
PT Kalbe Farma Tbk (“the Company” or “Kalbe”) was incorporated in 1996, and became a public company in 1991 upon the listing of its shares on the Indonesia Stock Exchange. Kalbe is the largest publicly-listed pharmaceutical company in Southeast Asia, with a market capitalization of USD 3.6 billion and sales revenues of Rp 10.2 trillion as of end-2010.
Kalbe has focused its business in four divisions, with relatively balanced contributions: prescription pharmaceuticals (a contribution of 25%), consumer health products (a contribution of 17%), nutritionals (a contribution of 22%) and distribution & packaging (a contribution of 36%). Supported by over 15,000 employees, inclusive of 4,000 sales and marketing professionals covering the entire Indonesian archipelago, Kalbe maintains coverage of more than 70% of general practitioners, 90% of specialists, 100% of hospitals, 100% of pharmacies across Indonesia for the prescription pharmaceutical market and 80% for the consumer health and nutritionals markets.
A spirit of innovation has been an integral part of the Company’s growth since its inception, and is today continuously applied in the Kalbe Group environment, in the development of new products with selling points and new technology-based products, providing convenience for consumers. Through medical research and development activities Kalbe actively contributes to advancing the medical knowledge and practice throughout Indonesia, upgrading the quality of life while boosting the Company’s future growth.
Through productivity improvements, innovations in health and sound cash flow management, Kalbe is well positioned to sustain its growth as a strong pharmaceutical company in Indonesia. Supported by continuous improvements in business processes and human resources quality, Kalbe continues to improve, in the quest “to be the best Indonesian healthcare company, driven by innovation, strong brands and excellent management”. (Source: Kalbe Farma)
Head Office :
Gedung KALBE
Jl. Let. Jend Suprapto Kav 4
Jakarta 10510
Indonesia
P.O. Box 3105 JAK.
Phone : 6221 - 42873888 - 89
Fax : 6221 - 42873680
Factory :
Kawasan Industri Delta Sillicon
Jl. MH Thamrin Blok A3-I
Lippo - Cikarang, Bekasi 17550
Indonesia
P.O. Box 371, Bekasi 17037
Phone : 6221 - 89907333-37
Fax : 6221 - 8972874
Currently we are opening 3 position below:
Regulatory Officer
Medical Executive Officer
Human Resource Information System
Sent your application not later than 2 weeks after this advertisement to:
Human Resources Department
PT. KALBE FARMA Tbk.
Jl. Let Jend Suprapto Kav 4 Cempaka Putih - Jakarta 10510
Ph. 021- 428 73 888
recruitment.corp@kalbe.co.id
Today, Kalbe is recognized as the largest regional pharmaceutical company in Southeast Asia. However, perhaps few people realize it all started in a small garage in the Tanjung Priok area of North Jakarta, Indonesia. When they set up Kalbe on September 10, 1966, the six founders may not have imagined that Kalbe could ever become the success that it is today. The sharp vision, high sense of entrepreneurship and spirit of hard work displayed by the founders and all the employees have enabled Kalbe to continue to grow and become the large and successful company of today.
Living by its philosophy, Kalbe always moves on and continues to grow. It is not surprising that nowadays Kalbe sells its products to Asian and African markets, as an expansion of its Indonesian market. By the end of 2005, Kalbe was represented at seven markets, namely Malaysia, the Philippines, Thailand, Vietnam, Myanmar, Sri Lanka and South Africa.
Nowadays Kalbe is engaged in both the consumer health business and the pharmaceutical products business to fulfill the diverse needs of their customers through the creation of many strong brands. In developing its business network and markets, Kalbe continues to produce many innovative products. Kalbe certainly always tries its best to fulfill the health requirements of all their valued customers, both in Indonesia and overseas.
To play the role of an innovator, Kalbe commits itself to the area of research and development. The research and development activities cover the creation of new medicines and formulations, new systems and processes, and new knowledge, either through its own capabilities or through strategic alliances with international partners. Indeed, to grow Kalbe must continue to innovate and always be on the constant lookout for potential global opportunities.
To ensure the availability of information at any time, anywhere, Kalbe has started the improvement of information technology in the extended Kalbe Group. This information technology will be an enabler and accelerator for Kalbe in expanding the business and providing the best services to all its customers.
With its wide scale of business and range of innovative products that continue to be trendsetters in the marketplace, Kalbe is a business group that is always in the forefront. Nonetheless, Kalbe will never stop. In the future, Kalbe is determined to be known not only as a regional company, but also as a global company active in the healthcare business and serving all the health needs of the general public.
PT Kalbe Farma Tbk (“the Company” or “Kalbe”) was incorporated in 1996, and became a public company in 1991 upon the listing of its shares on the Indonesia Stock Exchange. Kalbe is the largest publicly-listed pharmaceutical company in Southeast Asia, with a market capitalization of USD 3.6 billion and sales revenues of Rp 10.2 trillion as of end-2010.
Kalbe has focused its business in four divisions, with relatively balanced contributions: prescription pharmaceuticals (a contribution of 25%), consumer health products (a contribution of 17%), nutritionals (a contribution of 22%) and distribution & packaging (a contribution of 36%). Supported by over 15,000 employees, inclusive of 4,000 sales and marketing professionals covering the entire Indonesian archipelago, Kalbe maintains coverage of more than 70% of general practitioners, 90% of specialists, 100% of hospitals, 100% of pharmacies across Indonesia for the prescription pharmaceutical market and 80% for the consumer health and nutritionals markets.
A spirit of innovation has been an integral part of the Company’s growth since its inception, and is today continuously applied in the Kalbe Group environment, in the development of new products with selling points and new technology-based products, providing convenience for consumers. Through medical research and development activities Kalbe actively contributes to advancing the medical knowledge and practice throughout Indonesia, upgrading the quality of life while boosting the Company’s future growth.
Through productivity improvements, innovations in health and sound cash flow management, Kalbe is well positioned to sustain its growth as a strong pharmaceutical company in Indonesia. Supported by continuous improvements in business processes and human resources quality, Kalbe continues to improve, in the quest “to be the best Indonesian healthcare company, driven by innovation, strong brands and excellent management”. (Source: Kalbe Farma)
Logo
Contact
Head Office :
Gedung KALBE
Jl. Let. Jend Suprapto Kav 4
Jakarta 10510
Indonesia
P.O. Box 3105 JAK.
Phone : 6221 - 42873888 - 89
Fax : 6221 - 42873680
Factory :
Kawasan Industri Delta Sillicon
Jl. MH Thamrin Blok A3-I
Lippo - Cikarang, Bekasi 17550
Indonesia
P.O. Box 371, Bekasi 17037
Phone : 6221 - 89907333-37
Fax : 6221 - 8972874
Jobs and Career
Currently we are opening 3 position below:
Regulatory Officer
Medical Executive Officer
Human Resource Information System
How to Apply
Sent your application not later than 2 weeks after this advertisement to:
Human Resources Department
PT. KALBE FARMA Tbk.
Jl. Let Jend Suprapto Kav 4 Cempaka Putih - Jakarta 10510
Ph. 021- 428 73 888
recruitment.corp@kalbe.co.id
0 comments:
Post a Comment